pain

Health By Isabella Cueto

Medical cannabis unlikely to benefit most chronic pain patients, international researchers say

Health By Claudia López Lloreda

In the same health system, Black patients are prescribed fewer opioids than white patients

Health By Elizabeth Cooney

Challenging the link between statins and muscle pain, patients report no difference in aches when taking drug or placebo

Health By Elizabeth Cooney

Elective, but not optional: Orthopedic patients eagerly await surgeries delayed by Covid-19

First Opinion By Daniel S. Goldberg

Pain doesn’t stigmatize people. We do that to each other

First Opinion By Nkeiruka Orajiaka

Some kids in pain need opioids. For doctors, that means walking a tightrope

In the Lab By Associated Press

U.S. awards $3 million to fill gaps in medical marijuana research

First Opinion By Dawn Rae Downton

Who is really behind a proposed new definition of pain?

Pharma By David Armstrong — ProPublica

Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing

Health By Lauren Joseph

Study: 2% of women have ‘persistent’ opioid use after childbirth

Health By Ruth Hailu

‘Sickle cell needs more funding’: An 18-year-old patient advocate calls on Washington to improve children’s health care

Special Report By Kaiser Health News

How the Kaiser-Johns Hopkins analysis was done

First Opinion By Ben Goodwin, Judy Butler and Adriane Fugh-Berman

Industry-funded attacks on the CDC’s opioid prescribing guideline are eroding public health

First Opinion By Julia Arnsten

Access to medical cannabis: a new health care disparity

First Opinion By William Fleischman and Joseph S. Ross

How Insys undermined an FDA effort to protect the public from dangerous opioids

Biotech By Damian Garde

Disappointing trial results dim hopes for a new class of pain drugs

Biotech By Damian Garde

How one company thinks unraveling cough can provide a new way to treat pain

In the Lab By Jacquelyn Corley

The case of a woman who feels almost no pain leads scientists to a new gene mutation

First Opinion By Dave Chase

The opioid crisis is partly fueled by insurers’ and employers’ approach to back pain

Health By Lev Facher

Study shows Purdue’s switch to ‘abuse-deterrent’ OxyContin helped drive a spike in hepatitis C infections

Health By Damian Garde

So good it hurts: Why drug makers looking to replace opioids want to keep some pain in the picture

Health By Casey Ross

Once a last resort, this pain therapy is getting a new life amid the opioid crisis

Health By Casey Ross

At glitzy Vegas tech show, chronic-disease gadgets to take center stage

Health By Lev Facher

Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178

The Pharmalot View By Ed Silverman

The military pushed it for the battlefield. The FDA went along. Is the newest opioid any better?